logo

Robert Schooley, MD

Robert Schooley, MD

Infectious Disease San Diego, CA

Professor, Medicine, UCSD School of Medicine

Office Address

Office Map
  • 200 West Arbor Drive Mc 8201
    Ucsd Medical Center
    San Diego, CA 92103
    Phone: (858) 822-0333
    Fax: (858) 822-5362

Dr. Schooley's Clinical Specialties & Interests

  • Infectious Disease: General Infectious Disease, HIV/AIDS Medicine
  • Clinical Interests: Hepatitis C; HIV-1; International Medicine

Dr. Schooley's Faculty Appointments & Work History

  • Clinical Assistant in MedicineMassachusetts General Hospital
    Boston, MA
    Clinical Assistant in Medicine (1981-1982); Attending Physician (1981-1990); Lecturer (1982-1990); Assistant in Medicine (1983-1986); Assistant Physician (1987-1989); Associate Physician (1990-present)
  • DirectorUniversity of California
    San Diego, CA
    Director (2002-2004); Assistant Professor of Medicine (2002-2004); Professor of Medicine and Head, Division of Infectious Diseases (2005-present); Academic Vice Chair (2007-present); Co-Director (2012-present)
  • Staff PhysicianUniversity of california San Diego Healthcare
    San Diego, CA
  • Staff PhysicianDenver Veterans Affairs Medical Center
    Denver, CO
  • PhysicianUniversity Hospital
    Denver, CO
  • Professor of MedicineUniversity of Colorado Health Sciences Center
    Denver, CO
    Associate Professor of Pediatrics (1990-1993)
  • ConsultantDenver Health & Hospitals
    Denver, CO
  • Associate Professor of MedicineCornell University School of Medicine
    New York, NY
  • Professor of MedicineUniversity of Texas
    San Antonio, TX
    Director (1986-1990); Associate Dean (1986-1990)
  • Consultant in Infectious DiseasesHarvard University Health Services
    Cambridge, MA
  • LecturerHarvard Medical School
    Boston, MA
    Lecturer (1980-1990); Instructor in Medicine (1981-1983); Professor of Medicine (1982-1990); Assistant Professor of Medicine (1983-1987); Associate Professor of Medicine (1987-1990)
  • Consultant in Internal MedicineMassachusetts Eye and Ear Infirmary
    Boston, MA
  • Associate Professor of MedicineUniversity of Connecticut School of Medicine
    Farmington, CT

Dr. Schooley's Education & Medical Training

  • Massachusetts General HospitalMassachusetts General HospitalFellowship, Infectious Disease
  • Johns Hopkins UniversityJohns Hopkins UniversityFellowship, Infectious Disease
  • Johns Hopkins Bayview Medical CenterJohns Hopkins Bayview Medical CenterResidency, Medicine
  • The Johns Hopkins HospitalThe Johns Hopkins HospitalInternship, Medicine
  • Johns Hopkins Univ Sch of MedJohns Hopkins University School of MedicineMedical School
  • Washington and Lee UniversityWashington and Lee UniversityOther Training, BS

Dr. Schooley's Certifications & Licensure

  • CA State Medical LicenseCA State Medical License2005 - 2014
  • CO State Medical LicenseCO State Medical License1990 - 2015
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine, 1977

Dr. Schooley's Awards, Honors, & Recognition

  • Arnold P. Gold FoundationGold DocArnold P. Gold Foundation, 2009
  • University of California, San DiegoChief Residents’ Clinical TeachingUniversity of California, San Diego, 2007
  • Bonfils-Stanton FoundationScience of MedicineBonfils-Stanton Foundation, 1999
  • Register to See 12 More...

Dr. Schooley's Publications & Presentations

PubMed | Citations by Web of Science®

Journal Articles

  • A Phase I Study of Combination Therapy with L-697, 661 and Zidovudine.Schooley RT, Campbell TB, Kuritzkes DR, Blaschke T, Stein DS, Rosandich ME, Phair J, Pottage JC, Messari FA, Collier A, Kahn J and the ACTG 184 Protocol Team, J AIDS & Human Retrovirology. 1996; 12:363-70
  • Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel.Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG and Volberding PA, International AIDS Society-USA. JAMA. 1996; 276:146-54
  • Virologic and Immunologic Benefits of Initial Combination Therapy with Zidovudine and Zalcitabine or Didanosine Compared to Zidovudine Monotherapy.Schooley RT, Raniirez-Ronda C, Lange JMA, Cooper DA, Lavelle J, Lefkowitz L, Moore M, Larder BA, St. Clair M, Mulder JW, McKinnis R, Pennington KN, Harrigan PR, Kingho..., J Infect Dis. 1996; 173:1354-66
  • Register to See 179 More...

Books/Book Chapters

  • AIDS and Other Manifestations of HIV Infection.Chapter: Antiretroviral ChemotherapyPage 827 - 840
    Schooley RT
    Editors: G.P. Wormser.Raven Press, New York
    Edition 4,
  • Mechanisms of Microbial Diseases.Chapter: Human Retroviruses: AIDS and Other DiseasesPage 376 - 388
    Schooley RT
    Editors: Engleberg NC, DiRita V and Dermody TS.Lippincott Williams and Wilkins
    Edition 4,
  • Cecil’s Textbook of Internal Medicine.Chapter: Epstein Barr Virus Infection
    Schooley RT
    Editors: .
  • Register to See 28 More...

Abstracts/Posters

  • Long-term propagation of New World primate T-lymphocytes in vitro.Falk Jr. LA, Silva D, Byington R and Schooley RT, Fifteenth International Leukocyte Culture Conference. Intercell Communicat in Leucocyte Function

Other

  • Therapeutic decision making in 1997.Cotton D, Bartlett J, Schooley R, Gulick R
  • Check, but not checkmate.Schooley RT, Antiviral Therapy. 1997; 2:68-9
  • Antiretroviral chemotherapy.Saag MS and Schooley RT, Curr Clin Top Infect Dis. 1998; 18:154- 79
  • Register to See 21 More...

Grant Support

  • Orally Active Nucleoside Phosphonates For Hepatitis C Virus
    Orally Active Nucleoside Phosphonates For Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases
    2009 - 2012
  • Multiplex Nucleic Acid Detection Devices For The Diagnosis Of Respiratory Viruses
    Multiplex Nucleic Acid Detection Devices For The Diagnosis Of Respiratory VirusesNational Institute Of Allergy And Infectious Diseases
    2007 - 2011
  • International Program
    International ProgramNational Institute Of Allergy And Infectious Diseases
    2006 - 2011
  • Research In Infectious Diseases
    Research In Infectious DiseasesNational Institute Of Allergy And Infectious Diseases
    2005 - 2011
  • Biochip Diagnostic Tool For Bt Induced Diseases
    Biochip Diagnostic Tool For Bt Induced DiseasesNational Institute Of Allergy And Infectious Diseases
    2005 - 2007
  • The Role Of Sex And HCV Co-Infection In HIV Therapy
    The Role Of Sex And HCV Co-Infection In HIV TherapyNational Institute Of Allergy And Infectious Diseases
    2004 - 2004
  • ACTG A5116:2 Regimen Trial For HIV Subjects
    ACTG A5116:2 Regimen Trial For HIV SubjectsNational Center For Research Resources
    2004 - 2004
  • U Of Colorado Center For AIDS Research
    U Of Colorado Center For AIDS ResearchNational Institute Of Allergy And Infectious Diseases
    2003 - 2004
  • Immunopathogenesis Of Acute HIV-1 Infection
    Immunopathogenesis Of Acute HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases
    2003 - 2003
  • Colorado Adult AIDS Clinical Trials Unit
    Colorado Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    2000 - 2003
  • Chemotherapy/Immunotherapy For HIV Infection
    Chemotherapy/Immunotherapy For HIV InfectionNational Center For Research Resources
    2000 - 2002
  • Subcutaneous IL-2 In Combination With Haart
    Subcutaneous IL-2 In Combination With HaartNational Center For Research Resources
    2000 - 2002
  • Dynamics Of HCV Infection During Antiretroviral Therapy
    Dynamics Of HCV Infection During Antiretroviral TherapyNational Center For Research Resources
    2000 - 2002
  • A5025 Phase II Random Study Of Hydroxyurea In Subj On Potent Antiretrovirals
    A5025 Phase II Random Study Of Hydroxyurea In Subj On Potent AntiretroviralsNational Center For Research Resources
    1999 - 2002
  • Phase II Stdy Indinavir+Nevirapine+Stavudine In Subj Prev Trtd W/ 141w94/Vx-478
    Phase II Stdy Indinavir+Nevirapine+Stavudine In Subj Prev Trtd W/ 141w94/Vx-478National Center For Research Resources
    1999 - 2002
  • Phase II Prolong Virologic Success &Optn For Failure In HIV Sub On Indinavir
    Phase II Prolong Virologic Success &Optn For Failure In HIV Sub On IndinavirNational Center For Research Resources
    1999 - 2002
  • Soft Gelatin Capsule Of Saquinavir In Comb WI Ritonavir Or Nelfinavir
    Soft Gelatin Capsule Of Saquinavir In Comb WI Ritonavir Or NelfinavirNational Center For Research Resources
    1999 - 2002
  • Phase III Trial:Efavirenz/ Nelfinavir In Combination WI Lamivudine/Zidovudine
    Phase III Trial:Efavirenz/ Nelfinavir In Combination WI Lamivudine/ZidovudineNational Center For Research Resources
    1999 - 2002
  • Actg384  Protease Inhibitor &/Or NON Nucleoside Reverse Trans Inhibitor
    Actg384 Protease Inhibitor &/Or NON Nucleoside Reverse Trans InhibitorNational Center For Research Resources
    1999 - 2002
  • Adult ACTG Central Group
    Adult ACTG Central GroupNational Institute Of Allergy And Infectious Diseases
    1999 - 2001
  • ACTG 323 Fluconazole As Therapy For Oropharyngeal Candidiasis
    ACTG 323 Fluconazole As Therapy For Oropharyngeal CandidiasisNational Center For Research Resources
    1999 - 2002
  • ACTG 362 Trials Of Azithromycin Prophylaxis To Prevent MAC Disease
    ACTG 362 Trials Of Azithromycin Prophylaxis To Prevent MAC DiseaseNational Center For Research Resources
    1999 - 2002
  • ACTG 398, Phase II Trial Of Amprenavir As PART Of Dual Protease Inhib
    ACTG 398, Phase II Trial Of Amprenavir As PART Of Dual Protease InhibNational Center For Research Resources
    1999 - 2002
  • Safety, Tolerability And Pharmacokinetics Of Thalidomide In HIV1 Patients
    Safety, Tolerability And Pharmacokinetics Of Thalidomide In HIV1 PatientsNational Center For Research Resources
    1998 - 1999
  • Actg368 Indinavir Sulfate, Dmp266 &1592u89 In HIV Infected Subjects
    Actg368 Indinavir Sulfate, Dmp266 &1592u89 In HIV Infected SubjectsNational Center For Research Resources
    1998 - 2002
  • Actg347 Phase II Study Of 141w94/Vx478 Monotherapy VS 141w94/Vx + Zidovudine
    Actg347 Phase II Study Of 141w94/Vx478 Monotherapy VS 141w94/Vx + ZidovudineNational Center For Research Resources
    1998 - 2000
  • 3 Maintenence Regimens For HIV Subjects REC Zidovudine, Lamivudine, Indinavir
    3 Maintenence Regimens For HIV Subjects REC Zidovudine, Lamivudine, IndinavirNational Center For Research Resources
    1998 - 2002
  • D4T VS DDI VS ZDV PLUS D4T VS ZDV PLUS DDI In HIV Infected Patients
    D4T VS DDI VS ZDV PLUS D4T VS ZDV PLUS DDI In HIV Infected PatientsNational Center For Research Resources
    1997 - 1999
  • Evaluation Of STD Therapy VS STD Therapy W/Msl 109 In AIDS Patients W/Cmv
    Evaluation Of STD Therapy VS STD Therapy W/Msl 109 In AIDS Patients W/CmvNational Center For Research Resources
    1997 - 1997
  • Random Dbl-Bld, Combination Of Nucleoside And Triple Convergent Therapy For HIV
    Random Dbl-Bld, Combination Of Nucleoside And Triple Convergent Therapy For HIVNational Center For Research Resources
    1997 - 1997
  • Trial To Evaluate Activity Of 141W94 In Patients With HIV Infection
    Trial To Evaluate Activity Of 141W94 In Patients With HIV InfectionNational Center For Research Resources
    1997 - 1997
  • Delavirdine And ZDV Or Didanosine VS ZDV And DDI Combination Therapy
    Delavirdine And ZDV Or Didanosine VS ZDV And DDI Combination TherapyNational Center For Research Resources
    1997 - 1997
  • ACTG 333--Hard Capsule And Soft Capsule Saquinavir VS Indinavir
    ACTG 333--Hard Capsule And Soft Capsule Saquinavir VS IndinavirNational Center For Research Resources
    1997 - 1999
  • Phase I/II Open-Label Trial Of Delavirdine Mesylate (Dlv, U-90152s)
    Phase I/II Open-Label Trial Of Delavirdine Mesylate (Dlv, U-90152s)National Center For Research Resources
    1997 - 1997
  • Virologic Responses To New Nucleoside Regimens After ZDV Or DDI Monotherapy
    Virologic Responses To New Nucleoside Regimens After ZDV Or DDI MonotherapyNational Center For Research Resources
    1997 - 2000
  • Interleukin 2 PLUS Antiretroviral Therapy VS Antiretroviral Therapy
    Interleukin 2 PLUS Antiretroviral Therapy VS Antiretroviral TherapyNational Center For Research Resources
    1997 - 1999
  • Phase II/III Double-Blind Study Of Amytryptilene/Mexiletine For HIV Neuropathy
    Phase II/III Double-Blind Study Of Amytryptilene/Mexiletine For HIV NeuropathyNational Center For Research Resources
    1997 - 1999
  • 1592U89 Alone And With Retrovir For HIV Infection (Glaxo/Wellcome (131-002)
    1592U89 Alone And With Retrovir For HIV Infection (Glaxo/Wellcome (131-002)National Center For Research Resources
    1997 - 1997
  • Zdv/Ddi Regimens On Measures Of Viral Burden In Early HIV-1 Infection
    Zdv/Ddi Regimens On Measures Of Viral Burden In Early HIV-1 InfectionNational Center For Research Resources
    1997 - 1999
  • Influence Of Risk Status For Disease Progression On The Response To Intervention
    Influence Of Risk Status For Disease Progression On The Response To InterventionNational Center For Research Resources
    1997 - 2000
  • Complications Of HIV Disease Agenda
    Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Immunopathogenesis Of Acute HIV-1 Infection
    Immunopathogenesis Of Acute HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases
    1997 - 2002
  • Core--Advanced Technology Laboratories
    Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • ACTG 320 Phase III Indinavir Sulfate
    ACTG 320 Phase III Indinavir SulfateNational Center For Research Resources
    1997 - 2000
  • HIV Disease Research Agenda
    HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • ACTG 315 Ritonavir, Zidovudine And Lamivudine In Advanced HIV 1 Disease
    ACTG 315 Ritonavir, Zidovudine And Lamivudine In Advanced HIV 1 DiseaseNational Center For Research Resources
    1997 - 2000
  • Immunology And Immune Based Therapy Agenda
    Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • ACTG 285 Stem Cell Mobilization And Harvesting With Filgrastim
    ACTG 285 Stem Cell Mobilization And Harvesting With FilgrastimNational Center For Research Resources
    1997 - 2000
  • Neurology Agenda
    Neurology AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Women'S Health Agenda
    Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Outcomes Committee Agenda
    Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Pharmacology Agenda
    Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Outreach Agenda
    Outreach AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • ACTG 175--Monotherapy VS Combination Therapy In HIV PTS, CD4 200-500
    ACTG 175--Monotherapy VS Combination Therapy In HIV PTS, CD4 200-500National Center For Research Resources
    1996 - 1997
  • Outcomes Committee Agenda
    Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • Pharmacology Agenda
    Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • Neurology Agenda
    Neurology AgendaNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • Women'S Health Agenda
    Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • Immunology And Immune Based Therapy Agenda
    Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • HIV Disease Research Agenda
    HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • Core--Advanced Technology Laboratories
    Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • Complications Of HIV Disease Agenda
    Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • AIDS Clinical Trials Unit
    AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • Dapsone And Atovaquone Study For PCP In HIV Infected Patients
    Dapsone And Atovaquone Study For PCP In HIV Infected PatientsNational Center For Research Resources
    1996 - 1999
  • Adult ACTG Central Group
    Adult ACTG Central GroupNational Institute Of Allergy And Infectious Diseases
    1996 - 1998
  • Phase II/III Clarithromycin Regimens For MAC In HIV Positive Patients
    Phase II/III Clarithromycin Regimens For MAC In HIV Positive PatientsNational Center For Research Resources
    1996 - 1997
  • HIV-1 Derived Immunogens In Infected Individuals W/500 CD4 Cells/Mm3
    HIV-1 Derived Immunogens In Infected Individuals W/500 CD4 Cells/Mm3National Center For Research Resources
    1996 - 1997
  • Outreach Agenda
    Outreach AgendaNational Institute Of Allergy And Infectious Diseases
    1996 - 1999
  • 1592U89 Alone And With Retrovir For HIV Infection
    1592U89 Alone And With Retrovir For HIV InfectionNational Center For Research Resources
    1996 - 1996
  • Conference On Immunopathogenesis Of HIV Infection
    Conference On Immunopathogenesis Of HIV InfectionNational Institute Of Allergy And Infectious Diseases
    1996 - 1996
  • Short Term Clinical And Virologic Significance Of ZDV Resistance
    Short Term Clinical And Virologic Significance Of ZDV ResistanceNational Center For Research Resources
    1996 - 1996
  • ACTG 303--Influence Of Risk Status For Disease Progression
    ACTG 303--Influence Of Risk Status For Disease ProgressionNational Center For Research Resources
    1996 - 1996
  • ACTG 193a--Nucleoside And Triple Convergent Therapy For HIV
    ACTG 193a--Nucleoside And Triple Convergent Therapy For HIVNational Center For Research Resources
    1996 - 1996
  • ACTG 276--Various Zdv/Ddi Regimens On Measures Of Viral Burden
    ACTG 276--Various Zdv/Ddi Regimens On Measures Of Viral BurdenNational Center For Research Resources
    1996 - 1996
  • ACTG 261--Delavirdine And ZDV VS ZDV And DDI Combination Therapy
    ACTG 261--Delavirdine And ZDV VS ZDV And DDI Combination TherapyNational Center For Research Resources
    1996 - 1996
  • ACTG 260--Phase I/II Trial Of Delavirdine Mesylate
    ACTG 260--Phase I/II Trial Of Delavirdine MesylateNational Center For Research Resources
    1996 - 1996
  • ACTG 259--Phase II SC 49483 With ZDV Versus ZDV
    ACTG 259--Phase II SC 49483 With ZDV Versus ZDVNational Center For Research Resources
    1996 - 1996
  • ACTG 248--Interleukin 2 PLUS Antiretroviral Therapy VS Antiretroviral Therapy
    ACTG 248--Interleukin 2 PLUS Antiretroviral Therapy VS Antiretroviral TherapyNational Center For Research Resources
    1996 - 1996
  • ACTG 241--Ddi PLUS Nevirapine Versus ZDV PLUS DDI
    ACTG 241--Ddi PLUS Nevirapine Versus ZDV PLUS DDINational Center For Research Resources
    1996 - 1996
  • ACTG 209--Phase I/II Trial Vaccine Therapy In HIV1 Infected Individuals
    ACTG 209--Phase I/II Trial Vaccine Therapy In HIV1 Infected IndividualsNational Center For Research Resources
    1996 - 1996
  • ACTG 206--Alpha Interferon With DDI For Patients With Kaposis Sarcoma
    ACTG 206--Alpha Interferon With DDI For Patients With Kaposis SarcomaNational Center For Research Resources
    1996 - 1996
  • ACTG 204a--Valacyclovir Hydrocholoride Study In HIV Positive Patients
    ACTG 204a--Valacyclovir Hydrocholoride Study In HIV Positive PatientsNational Center For Research Resources
    1996 - 1996
  • ACTG 290-D4t VS DDI VS ZDV PLUS D4T VS ZDV PLUS DDI In HIV Positive Patients
    ACTG 290-D4t VS DDI VS ZDV PLUS D4T VS ZDV PLUS DDI In HIV Positive PatientsNational Center For Research Resources
    1996 - 1996
  • Ribozymes As Molecular Therapies For AIDS
    Ribozymes As Molecular Therapies For AIDSNational Institute Of Allergy And Infectious Diseases
    1994 - 1996
  • AIDS Clinical Trials
    AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases
    1994 - 1995
  • University Of Colorado HIV Research Training Program
    University Of Colorado HIV Research Training ProgramNational Institute Of Allergy And Infectious Diseases
    1992 - 2003
  • Colorado AIDS Clinical Trials Unit
    Colorado AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    1992 - 1993
  • Cell Mediated Immune Response To Human Retroviruses
    Cell Mediated Immune Response To Human RetrovirusesNational Cancer Institute
    1990 - 1994
  • AIDS &Related Research 1 Study Section
    AIDS &Related Research 1 Study SectionCenter For Scientific Review
    1990 - 1990
  • Cellular Immune Response To HIV
    Cellular Immune Response To HIVNational Cancer Institute
    1987 - 1989
  • Human T-Cell Leukemia Virus--Virus-Host Interactions
    Human T-Cell Leukemia Virus--Virus-Host InteractionsNational Cancer Institute
    1985 - 1986

Committees

  • NIH Drug Discovery and Resistance (DDR) Study SectionChair2011 - Present
  • Scientific Advisory Board, PEPFAR, US Department of StateMember2011 - Present

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS California CaliforniaCare HMO
  • BCBS California PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO
  • Pacificare HMO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Schooley's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV